Related Experiment Video
Updated: Feb 26, 2026

A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology
Published on: March 17, 2016
Minocycline reduces microgliosis and improves subcortical white matter function in a model of cerebral vascular
Yasmina Manso1, Philip R Holland1, Akihiro Kitamura1
1Centre for Neuroregeneration, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, United Kingdom.
Abstract:
Chronic cerebral hypoperfusion is a key mechanism associated with white matter disruption in cerebral vascular disease and dementia. In a mouse model relevant to studying cerebral vascular disease, we have previously shown that cerebral hypoperfusion disrupts axon-glial integrity and the distribution of key paranodal and internodal proteins in subcortical myelinated axons. This disruption of myelinated axons is accompanied by increased microglia and cognitive decline. The aim of the present study was to investigate whether hypoperfusion impairs the functional integrity of white matter, its relation with axon-glial integrity and microglial number, and whether by targeting microglia these effects can be improved. We show that in response to increasing durations of hypoperfusion, the conduction velocity of myelinated fibres in the corpus callosum is progressively reduced and that paranodal and internodal axon-glial integrity is disrupted. The number of microglial cells increases in response to hypoperfusion and correlates with disrupted paranodal and internodal integrity and reduced conduction velocities. Further minocycline, a proposed anti-inflammatory and microglia inhibitor, restores white matter function related to a reduction in the number of microglia. The study suggests that microglial activation contributes to the structural and functional alterations of myelinated axons induced by cerebral hypoperfusion and that dampening microglia numbers/proliferation should be further investigated as potential therapeutic benefit in cerebral vascular disease.
Insights
Chronic cerebral hypoperfusion impairs white matter function and axon integrity, leading to cognitive decline. Targeting microglia with minocycline may restore white matter function in cerebral vascular disease.
Area of Science:
- Neuroscience
- Cerebrovascular Research
- White Matter Integrity
Background:
- Chronic cerebral hypoperfusion is a key factor in white matter damage in cerebral vascular disease and dementia.
- Previous studies showed hypoperfusion disrupts axon-glial integrity and protein distribution in myelinated axons, increasing microglia and causing cognitive decline.
Purpose of the Study:
- To investigate how hypoperfusion affects white matter functional integrity.
- To examine the relationship between white matter integrity, axon-glial integrity, and microglial numbers.
- To determine if targeting microglia can ameliorate these effects.
Main Methods:
- Utilized a mouse model of cerebral vascular disease.
- Measured conduction velocity in corpus callosum myelinated fibers.
- Assessed paranodal and internodal axon-glial integrity.
- Quantified microglial cell numbers.
- Administered minocycline to evaluate its therapeutic potential.
Main Results:
- Progressive reduction in conduction velocity with increasing hypoperfusion duration.
- Disruption of paranodal and internodal axon-glial integrity.
- Increased microglial numbers correlated with impaired white matter function.
- Minocycline treatment restored white matter function by reducing microglial numbers.
Conclusions:
- Microglial activation contributes to structural and functional white matter damage caused by cerebral hypoperfusion.
- Reducing microglial proliferation or numbers may offer therapeutic benefits for cerebral vascular disease.
More Related Videos
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
08:22Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025